Increased sensitivity to long-term 5-fluorouracil exposure of human colon cancer HT-29 cells resistant to short-term exposure

被引:7
作者
Inaba, M [1 ]
Tanaka, T [1 ]
Sawada, H [1 ]
机构
[1] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Toshima Ku, Tokyo 1708455, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1998年 / 89卷 / 03期
关键词
HT-29 human colon cancer; 5-fluorouracil-resistance; dual actions of 5-FU; exposure time;
D O I
10.1111/j.1349-7006.1998.tb00565.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 5-fluorouracil (5-FU)-resistant subline of human colon cancer HT-29 cells was developed by repeated 1-h exposure in vitro to 5-FU. This subline (HT-29/5-FU/S) had 8-fold resistance to 5-FU in a 1-h exposure assay. However, it had rather increased sensitivity to 5-FU when assayed after a continuous 96-h exposure to it, Significantly less 5-fluorouridine-5'-triphosphate mas produced in the resistant cells, leading to a lower level of 5-FU incorporation into the cellular RNA, The reduced activity of orotate phosphoribosyltransferase might explain these results, In contrast, the HT-29/5-FU/S cells were more sensitive to the inhibition of in situ thymidylate synthase (TS) by 5-FU than were the parent cells, The lower in situ TS activity may have made HT-29/5-FU/S cells more sensitive to TS inhibition by 5-FU as compared with the parent cells, The fact that HT-29/5-FU/S was more resistant to short-term 5-FU exposure but more sensitive to long-term exposure than the parent line confirmed the existence of different modes of action of 5-FU, depending on the exposure time.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 13 条
[1]  
ASCHELE C, 1992, CANCER RES, V52, P1855
[2]   THYMIDYLATE SYNTHASE GENE AMPLIFICATION IN HUMAN COLON-CANCER CELL-LINES RESISTANT TO 5-FLUOROURACIL [J].
COPUR, S ;
AIBA, K ;
DRAKE, JC ;
ALLEGRA, CJ ;
CHU, E .
BIOCHEMICAL PHARMACOLOGY, 1995, 49 (10) :1419-1426
[3]  
GREM JL, 1986, CANCER RES, V46, P6191
[4]   Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells [J].
Inaba, M ;
Mitsuhashi, J ;
Sawada, H ;
Miike, N ;
Naoe, Y ;
Daimon, A ;
Koizumi, K ;
Tsujimoto, H ;
Fukushima, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (02) :212-220
[5]  
INABA M, 1994, ONCOL RES, V6, P303
[6]   KINETIC-ANALYSIS OF 5-FLUOROURACIL ACTION AGAINST VARIOUS CANCER-CELLS [J].
INABA, M ;
MITSUHASHI, J ;
OZAWA, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1990, 81 (10) :1039-1044
[7]   FEASIBILITY OF A HIGH-FLUX ANTICANCER DRUG SCREEN USING A DIVERSE PANEL OF CULTURED HUMAN TUMOR-CELL LINES [J].
MONKS, A ;
SCUDIERO, D ;
SKEHAN, P ;
SHOEMAKER, R ;
PAULL, K ;
VISTICA, D ;
HOSE, C ;
LANGLEY, J ;
CRONISE, P ;
VAIGROWOLFF, A ;
GRAYGOODRICH, M ;
CAMPBELL, H ;
MAYO, J ;
BOYD, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) :757-766
[8]  
OZAWA S, 1988, CANCER CHEMOTH PHARM, V21, P185
[9]  
OZAWA S, 1989, CANCER RES, V49, P3823
[10]  
PETERS GJ, 1986, CANCER RES, V46, P20